Adjuvant Chemotherapy in Patients with Low-Risk Epithelial Ovarian Cancer: A Taiwanese Cohort Study
Background: Whether or not patients with stage I epithelial ovarian cancer (EOC) benefit from postoperative chemotherapy in the Asian population remains unclear. This retrospective cohort study was aimed at investigating the use of adjuvant chemotherapy in clinical practice to treat patients with ea...
Saved in:
Main Authors: | Yuan-Ting C. Lo, Hsiu-Ying Ku, Cheng-Shyong Chang, Hui-Ju Ch’ang, Chih-Ming Ho, Tsang-Wu Liu, Shih-Min Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-04-01
|
Series: | Journal of Cancer Research and Practice |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/ejcrp.eJCRP-D-23-00003 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adjuvant chemotherapy followed by concurrent chemoradiation is associated with improved survival for resected stage I‐II pancreatic cancer
by: Sung Jun Ma, et al.
Published: (2019-03-01) -
Transcription factor A, mitochondrial promotes lymph node metastasis and lymphangiogenesis in epithelial ovarian carcinoma
by: Wubuli Reziwanguli, et al.
Published: (2025-02-01) -
Assessment of the Effects of Chemotherapy on Ovarian Reserve in Rats
by: Ahmet Mete Ergenoğlu, et al.
Published: (2014-04-01) -
Characterization of tumor prognosis and sensitive chemotherapy drugs based on cuproptosis-related gene signature in ovarian cancer
by: Wei Tan, et al.
Published: (2025-01-01) -
Risk Stratification and Adjuvant Chemotherapy for High‐Risk Stage IA Lung Adenocarcinoma: The Unmet Needs
by: Chen Shen, et al.
Published: (2025-01-01)